First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

被引：0
|
作者：
Djelila Allouache
Sulochana R Gawande
Michele Tubiana-Hulin
Nicole Tubiana-Mathieu
Sophie Piperno-Neumann
Fawzia Mefti
Laurence Bozec
Jean-Yves Genot
机构：
[1] Lion sur mer,Centre F. Baclesse
[2] Lilly Corporate,Eli Lilly and Company
[3] Ctr René Huguenin,undefined
[4] Hopital Dupuytren,undefined
[5] Hospital Curie,undefined
[6] Lilly France,undefined
来源：
BMC Cancer | / 5卷
关键词：
Paclitaxel; Gemcitabine; Metastatic Breast Cancer; Anthracyclines; Inflammatory Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A phase II trial of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
    Meshref, M. M.
    Samir, S.
    Saad, E.
    Gouda, Y.
    Elmesidy, S.
    Koheil, H.
    Elzawahri, H.
    Kandil, A.
    Abdelhamid, T.
    Zaki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Phase II Trial with Gemcitabine, Paclitaxel and Bevacizumab for the First Line Treatment of Metastatic Breast Cancer.
    Guardino, A. E.
    Chen, M.
    Levy, M.
    Chen, M.
    CANCER RESEARCH, 2009, 69 (24) : 853S - 853S
  • [33] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    Ciardiello, F.
    Troiani, T.
    Caputo, F.
    De Laurentiis, M.
    Tortora, G.
    Palmieri, G.
    De Vita, F.
    Diadema, M. R.
    Orditura, M.
    Colantuoni, G.
    Gridelli, C.
    Catalano, G.
    De Placido, S.
    Bianco, A. R.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1604 - 1609
  • [34] Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
    F Ciardiello
    T Troiani
    F Caputo
    M De Laurentiis
    G Tortora
    G Palmieri
    F De Vita
    M R Diadema
    M Orditura
    G Colantuoni
    C Gridelli
    G Catalano
    S De Placido
    A R Bianco
    British Journal of Cancer, 2006, 94 : 1604 - 1609
  • [35] Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer:: Results of a multicenter phase II study
    Palmeri, S
    Vaglica, M
    Spada, S
    Filippelli, G
    Farris, A
    Palmeri, L
    Massidda, B
    Misino, A
    Ferraù, F
    Comella, G
    Leonardi, V
    Condemi, G
    Mangiameli, A
    De Cataldis, G
    Macaluso, MC
    Cajozzoo, M
    Iannitto, E
    Danova, M
    ONCOLOGY, 2005, 68 (4-6) : 438 - 445
  • [36] Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
    Lobo, Christopher
    Lopes, Gilberto
    Baez, Odalys
    Castrellon, Aurelio
    Ferrell, Annapoorna
    Higgins, Connie
    Hurley, Erin
    Hurley, Judith
    Reis, Isildinha
    Richman, Stephen
    Seo, Pearl
    Silva, Orlando
    Slingerland, Joyce
    Tukia, Keleni
    Welsh, Catherine
    Glueck, Stefan
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (02) : 427 - 435
  • [37] Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
    Christopher Lobo
    Gilberto Lopes
    Odalys Baez
    Aurelio Castrellon
    Annapoorna Ferrell
    Connie Higgins
    Erin Hurley
    Judith Hurley
    Isildinha Reis
    Stephen Richman
    Pearl Seo
    Orlando Silva
    Joyce Slingerland
    Keleni Tukia
    Catherine Welsh
    Stefan Glück
    Breast Cancer Research and Treatment, 2010, 123 : 427 - 435
  • [38] Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer
    Hitt, R
    Paz-Ares, L
    Hidalgo, M
    Colomer, R
    Brandariz, A
    Peña, M
    Alvarez-Vicent, J
    Hornedo, J
    Cortés-Funes, H
    SEMINARS IN ONCOLOGY, 1997, 24 (06) : S20 - S24
  • [39] Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer
    Luck, HJ
    Thomssen, C
    duBois, A
    Lisboa, BW
    Untch, M
    Kuhnle, H
    Janicke, F
    Meerpohl, HG
    Lindner, C
    Kcnecny, G
    Hecker, D
    Diergarten, K
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S13 - S16
  • [40] First-line paclitaxel and cisplatin used sequentially or in combination in metastatic breast cancer: A phase II randomized study
    Elserafi, Mostafa M.
    Zeeneldin, Ahmed A.
    Abdelsalam, Ibrahim M.
    Nassar, Hanan R.
    Moneer, Manar M.
    Buhoush, Wafa H.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2018, 30 (01) : 13 - 20
12345